Health Service Executive

Dáil Éireann Debate, Thursday - 4 December 2025

• Debates
• Find a debate
  • Dáil debates
  • Seanad debates
  • Committee debates
• Find a vote
  • Dáil votes
  • Seanad votes
  • Committee votes
• Parliamentary questions
  • Written questions
  • Oral questions
• Search tips
• Utterances having an adverse effect

Thursday, 4 December 2025

Questions (539)

Barry Ward

Question:

539. Deputy Barry Ward asked the Minister for Health if dupilumab will be made available through the HSE for the treatment of juvenile eosinophilic oesophagitis; and if she will make a statement on the matter. [68978/25]

Written answers

Minister for Health

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and medical devices; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

• Previous Answer
• Next Answer